On Track for U.S. and Global Market Approvals

LYON, France , Jan. 3, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of

Strengthens Leading Position in Second Largest Asian Lithotripsy Market

LYON, France , Dec. 7, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today that its Sonolith lithotripter products, including Sonolith i-sys and Sonolith i-move, has been exclusively registered by UGAP, the French Public Purchasing Agency

LYON, France , Nov. 23, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today that its new lithotripter Sonolith i-move received the Best 2010 Product Innovation award by the French economic journal Bref Rhone-Alpes .

Third Quarter Highlights   Revenues increased 15.5% year-over-year to EUR 5.3 million ( USD 7.0 million ) Gross margin rose 500 basis points over last year to 41.6% Operating loss, excluding lower FDA clinical trial expense, improved by EUR 576,000 to EUR 404,000 Net loss improved by EUR 3.9

Agreement With Epitarget AS and INSERM

LYON, France, Oct 27, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the details relating to its third quarter 2010 results announcement, which will take place on Wednesday, November 17, 2010, before the

Plan for Second, Larger Trial

Oct 7, 2010 (GlobeNewswire via COMTEX News Network) -- Focus on World's Largest Lithotripsy Market Installs First Sonolith i-sys in Japan LYON, France, Oct. 7, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has strengthened